Data presented at EHA strengthens Mendus’ programs in myeloid leukemias

What we doOur approachPipelineTechnologyPublicationsPatient and Clinical Perspectives
About usExecutive ManagementBoard of DirectorsScientific Advisory Board
News & eventsPress releasesEventsInterviews
Investors
Careers

Back
Data presented at EHA strengthens Mendus’ programs in myeloid leukemias
 8:00:00 AM

Keep reading
Change in number of shares and votes in Mendus AB (publ)Read